Chromadex Corp (NAGE): יחס שווי שוק להכנסות החברה

Despite the risks of global raw material supply chain disruptions, ChromaDex Corp (NAGE) management is focusing on patents in the field of cellular longevity. The P/S ratio trend clearly demonstrates the balance between market value and actual sales, where 1.40 serves as the current metric level. The brand's high authority in the anti-aging components segment promises stable growth in share prices in the future.

Chromadex Corp. supplement sales are subject to moderate cyclicality and are sensitive to consumer wellness spending. Analyzing the historical P/S chart, an investor can observe the ratio of market capitalization to annual revenue, which allows for an assessment of the value of each dollar of sales and determines whether the asset's current price is justified by the business's actual cash flows.